Q4 2025 Healthcare M&A Spotlight

January 8, 2026 | Insights

Deal activity should build slightly in Q1, while we expect timelines to remain extended due to the intensity of buy-side diligence. We expect sponsor-backed platforms to be more acquisitive in 2026 than in the prior two years. We should continue to see high multiples for good assets in in-demand sectors. This report explores broad M&A market trends and insights into Bailey & Company’s four main coverage areas: healthcare services, healthcare IT & tech-enabled services, payer services, and pharma services, life sciences & medtech.

Download the report by filling out the form. Please contact us to request more information.

Download Now




    CONTACT INFORMATION

    Rebecca Springer - Bailey & Company

    Rebecca Springer

    Senior Director, Market Development

    Collin Anderson

    Senior Analyst, Market Development

    ABOUT BAILEY & COMPANY

    Bailey & Company is a Nashville-based merchant banking platform focused on middle market healthcare companies in the healthcare services, healthcare technology, payer services and pharma services/medtech/life sciences sectors. As one of the largest independent, sector-focused investment banking and investing platforms in the country, Bailey & Company supports strong management teams that have built scalable platforms by providing strategic insights, world-class advice and access to one of the most diverse networks of industry experts. For more information see: www.bnco.com

    We’re here to help you achieve your strategic objectives.

    Let’s have a conversation about how we can put our deep expertise to work for you.

    Send Us A Message